跳至主要内容
临床试验/NCT06160869
NCT06160869进行中(未招募)不适用

Efficacy of Acceptance and Commitment Therapy on Psychotic Severity Among Inpatients With Primary Psychosis: A Randomized Controlled Trial.

Port Said University1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2023年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
76
试验地点
1
主要终点
Positive and Negative Syndrome Scale (PANSS)

研究概览

简要总结

Our study aims to assess the efficacy of Acceptance and Commitment Therapy on psychotic severity among Inpatients with primary psychosis: A Randomized Controlled Trial.

详细描述

Current study was an open label, two-arm, parallel, randomized controlled trial, evaluating the efficiency of Acceptance and Commitment Therapy (ACT) added to treatment as usual (TAU) as opposed to treatment as usual (TAU) alone on patients with schizophrenia. The study adheres to the rules for writing Clinical Trials: "The Consolidated Standards of Reporting Trials" (CONSORT) statement

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

盲法说明

Information is not withheld from trial participants

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participants' criteria of inclusion involved those patients who were
  • •Current psychiatric hospitalization;
  • •DSM-5 diagnosis of a primary psychotic disorder; (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder, brief psychotic disorder, and unspecified psychotic disorder, this diagnosis was confirmed by a psychiatrist
  • •18 years or older;
  • •ability to talk, read and write in Arabic; and
  • •willingness to participate in the study that was scheduled for seven weeks.

排除标准

  • •Patients were excluded if they
  • •had a comorbid learning disability or organic brain disorder;
  • •psychosis related to a general medical condition or substance-induced psychotic disorder;
  • •were considered mentally unstable; or
  • •unfit to participate in the study by their therapist, and/or had newly had (been receiving) psycho-education or somewhat designed psychosocial intervention.

研究组 & 干预措施

ACT Group

Experimental

Received 90-minutes weekly group sessions of acceptence and commitment therapy plus treatment as usual.

干预措施: Acceptance and commitment therapy (Behavioral)

Treatment as usual (TAU) group

Active Comparator

Will receive the TAU alone

干预措施: Treatment as usual (Combination Product)

结局指标

主要结局

Positive and Negative Syndrome Scale (PANSS)

时间窗: 7 weeks

Measuring symptom severity of patients with schizophrenia. This is a 30-item instrument. Rating of each item is from (one, no evidence) to (seven, strong evidence) and the total score for overall psychopathology ranges from 30 to 210.

次要结局

  • Difficulties in Emotion Regulation Scale(7 weeks)
  • Recovery Assessment Scale(7 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验